Meeting
2021 Gastrointestinal Cancers Symposium
Impact of systemic inflammation and sarcopenia on prognosis of metastatic colorectal cancer.
Authors
David da Silva Dias
Centro Hospitalar Universitário do Algarve, Faro, Portugal
David da Silva Dias , Mafalda Machado , Beatriz Gosalbez , Paula Ravasco
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Colorectal Cancer
Track
Colorectal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 38)
DOI
10.1200/JCO.2021.39.3_suppl.38
Abstract #
38
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Management of Early-onset Metastatic Colorectal Cancer (ERMIONE): A single institution analysis.
First Author: Giustina Valente
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Analysis of the impact of eliminating bolus 5-fluorouracil in metastatic colorectal cancer.
First Author: Chengwei Peng
Poster
2020 Gastrointestinal Cancers Symposium
Association of sarcopenia and myosteatosis with the systemic inflammatory response and tumor stage in patients undergoing surgery for colorectal cancer (CRC).
First Author: Tanvir Abbass
Poster
2020 Gastrointestinal Cancers Symposium
Quattro-II study: A multicenter randomized phase II study comparing capoxiri plus bevacizumab with FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer as the first-line treatment.
First Author: Akihito Tsuji